SG/CALL/ABBOTT LABORATORIES/100/0.1/20.09.24 Share Price

Warrant

DE000SQ3G8X8

Market Closed - Deutsche Boerse AG 20:38:00 21/06/2024 BST
0.8 EUR -11.11% Intraday chart for SG/CALL/ABBOTT LABORATORIES/100/0.1/20.09.24
Current month+37.93%
1 month+17.65%
Date Price Change
21/06/24 0.8 -11.11%
20/06/24 0.9 +38.46%
19/06/24 0.65 -7.14%
18/06/24 0.7 +2.94%
17/06/24 0.68 -1.45%

Delayed Quote Deutsche Boerse AG

Last update June 21, 2024 at 08:38 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ3G8X
ISINDE000SQ3G8X8
Date issued 27/10/2022
Strike 100 $
Maturity 20/09/2024 (89 Days)
Parity 10 : 1
Emission price 1.87
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.55
Lowest since issue 0.49
Delta0.72x
Omega 8.619
Premium2.93x
Gearing11.98x
Moneyness 1.057
Difference Strike -5.72 $
Difference Strike %-5.72%
Spread 0.01
Spread %1.20%
Intrinsic value 0.5349

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.7 USD
Average target price
125.2 USD
Spread / Average Target
+18.39%
Consensus